Is Hematopoietic Stem Cell Transplantation Required to Unleash the Full Potential of Immunotherapy in Acute Myeloid Leukemia?

From monoclonal antibodies (mAbs) to Chimeric Antigen Receptor (CAR) T cells, immunotherapies have enhanced the efficacy of treatments against B cell malignancies. The same has not been true for Acute Myeloid Leukemia (AML). Hematologic toxicity has limited the potential of modern immunotherapies fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Abadir, Edward, Gasiorowski, Robin E., Silveira, Pablo A., Larsen, Stephen, Clark, Georgina J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073661/
https://www.ncbi.nlm.nih.gov/pubmed/32085578
http://dx.doi.org/10.3390/jcm9020554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073661/
https://www.ncbi.nlm.nih.gov/pubmed/32085578
http://dx.doi.org/10.3390/jcm9020554

Ejemplares similares